CD8A and neoplasm: In another study, cisplatin/vinorelbine in combination with a yeast-based vaccine promoted an antigen-specific CD8+ T cell response and increased the tumor surface expression of Fas, which increases sensitivity to CTL-mediated killing, thereby improving the survival of non-small-cell lung-cancer-bearing mice [98].